Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
right	O
hydronephrosis,	O
unclear	O
etiology	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
___:	O
Cystoscopy,	O
right	O
retrograde	O
pyelogram.	O
___:	O
___	O
R	O
PCN	O
placed	O
at	O
___	O
___:	O
Exchange	O
of	O
___	O
to	O
a	O
___	O
Right	O
PCN	O
at	O
___	O
___:	O
___	O
retroperitoneal	O
mass	O
biopsy	O
by	O
___	O
___:	O
___	O
re-attempt	O
at	O
biopsy	O
of	O
RP	O
mass	O
___:	O
Laparoscopic	O
right	O
oophorectomy/removal	O
of	O
pelvic	O
mass	O
including	O
portion	O
of	O
round	O
ligament	O
and	O
distal	O
fallopian	O
tube.	O
History	O
of	O
Present	O
Illness:	O
Patient	O
is	O
a	O
___	O
female	O
with	O
a	O
history	O
of	O
DM,	O
HTN,	O
CAD,	O
CHF,	O
CKD,	O
vaginal	O
prolapse	O
s/p	O
surgical	O
repair	O
many	O
years	O
ago	O
who	O
underwent	O
TAVR	O
on	O
___.	O
During	O
that	O
hospital	O
stay	O
she	O
endorsed	O
severe	O
RLQ/pelvic	O
pain	O
and	O
abdominal	O
imaging	O
was	O
obtained	O
which	O
showed	O
right	O
hydronephrosis	O
of	O
unclear	O
etiology,	O
possibly	O
due	O
to	O
an	O
abdominal	O
mass	O
which	O
was	O
not	O
well	O
defined	O
on	O
the	O
scan.	O
She	O
underwent	O
cystoscopy	O
and	O
attempted	O
right	O
ureteral	O
stent	O
placementon	O
___	O
as	O
a	O
planned	O
day	O
surgical	O
procedure;	O
a	O
wire	O
was	O
able	O
to	O
be	O
advanced	O
into	O
the	O
right	O
renal	O
pelvis	O
but	O
unfortunately	O
a	O
stent	O
was	O
unable	O
to	O
be	O
passed.	O
She	O
was	O
therefore	O
admitted	O
to	O
urology	O
for	O
___	O
consultation	O
and	O
PCN	O
placement.	O
Past	O
Medical	O
History:	O
PAST	O
MEDICAL	O
HISTORY:	O
1.	O
CARDIAC	O
RISK	O
FACTORS	O
-	O
Type	O
2	O
Diabetes	O
-	O
Hypertension	O
-	O
Dyslipidemia	O
2.	O
CARDIAC	O
HISTORY	O
-	O
CABG:	O
5	O
vessel,	O
___	O
-	O
PERCUTANEOUS	O
CORONARY	O
INTERVENTIONS:	O
___	O
-	O
PACING/ICD:	O
None	O
-	O
Severe	O
aortic	O
stenosis	O
-	O
EF	O
45%	O
*Patient	O
NYHA	O
Class	O
II*	O
3.	O
OTHER	O
PAST	O
MEDICAL	O
HISTORY	O
Iron	O
deficiency	O
anemia	O
Stage	O
IV	O
CKD	O
GERD	O
H/o	O
GI	B-Upper_gastrointestinal_haemorrhage
bleed	B-Upper_gastrointestinal_haemorrhage
with	O
no	O
source	O
identified	O
in	O
___	O
Obesity	O
Macular	B-Visual_impairment
degeneration	B-Visual_impairment
Peripheral	O
vascular	O
disease	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
deceased	O
of	O
complications	O
from	O
diabetes	O
in	O
his	O
late	O
___.	O
Mother	O
deceased	O
in	O
her	O
___.	O
Brother	O
with	O
history	O
of	O
angina.	O
Daughter	O
recently	O
passed	O
away	O
from	O
BMT	O
rejection.	O
Physical	O
Exam:	O
Admission	O
Exam:	O
VS:	O
97.6	O
180/78	O
86	O
20	O
94%	O
RA	O
-	O
AAOx4,	B-Delirium
NAD;	O
frail	B-Frailty
appearing	O
elderly	O
female	O
lying	O
in	O
bed	O
in	O
no	O
acute	O
distress,	O
appearing	O
slightly	O
older	O
than	O
stated	O
age	O
-	O
breathing	O
unlabored	O
on	O
RA	O
-	O
skin	O
WWP	O
-	O
abdomen	O
soft,	O
NT,	O
ND;	O
endorsing	O
right	O
flank	O
and	O
pelvic	O
pain	O
-	O
moving	O
all	O
extremities	O
spontaneously	O
Discharge	O
Exam:	O
VS:	O
98.6	O
158/60	O
72	O
18	O
97%	O
on	O
RA	O
Gen	O
-	O
sitting	O
up	O
in	O
chair,	O
comfortable	O
appearing	O
Eyes	O
-	O
EOMI,	O
anicteric	O
sclera	O
ENT	O
-	O
OP	O
clear,	O
MMM	O
Heart	O
-	O
RR,	O
___	O
systolic	O
murmur	O
heard	O
best	O
at	O
b/l	O
USB	O
with	O
radiation	O
to	O
carotids	O
Lungs	O
-	O
CTA	O
bilaterally,	O
normal	O
WOB	O
Abd	O
-	O
soft,	O
mildly	O
tender	O
throughout;	O
laparoscopic	O
scars	O
clean;	O
no	O
rebound/guarding;	O
no	O
CVA	O
tenderness;	O
R	O
perc	O
nephrostomy	O
in	O
place;	O
bowel	O
sounds	O
present	O
Ext	O
-	O
trace	O
b/l	O
___	O
edema	O
Skin	O
-	O
no	O
rashes	O
Vasc	O
-	O
1+	O
DP/radial	O
pulses	O
Neuro	O
-	O
AOx3,	B-Delirium
moving	O
all	O
extremities,	O
clear	O
speech,	O
conversant	O
Psych	O
-	O
calm,	O
cooperative,	O
pleasant	O
Pertinent	O
Results:	O
Admission	O
Labs:	O
___	O
06:50AM	O
BLOOD	O
WBC-7.8	O
RBC-3.42*	O
Hgb-8.2*	O
Hct-28.0*	O
MCV-82	O
MCH-24.0*	O
MCHC-29.3*	O
RDW-18.4*	O
RDWSD-55.6*	O
Plt	O
___	O
___	O
06:50AM	O
BLOOD	O
___	O
PTT-32.4	O
___	O
___	O
06:50AM	O
BLOOD	O
Glucose-86	O
UreaN-19	O
Creat-1.6*	O
Na-141	O
K-3.9	O
Cl-107	O
HCO3-22	O
AnGap-16	O
Imaging/Studies:	O
___	O
___	O
Report:	O
Successful	O
placement	O
of	O
right	O
8	O
___	O
percutaneous	O
nephrostomy	O
tube.	O
Multiple	O
attempts	O
were	O
made	O
to	O
place	O
a	O
nephroureteral	O
stent	O
across	O
the	O
obstruction	O
at	O
the	O
proximal	O
ureter	O
however	O
this	O
is	O
unsuccessful.	O
___	O
___	O
Report:	O
IMPRESSION:	O
Technically	O
successful	O
exchange	O
of	O
the	O
existing	O
8	O
___	O
percutaneous	O
nephrostomy	O
tube	O
for	O
a	O
new	O
10	O
___	O
percutaneous	O
nephrostomy	O
tube.	O
___	O
&	O
___	O
Urine	O
Cytology:	O
Negative	O
for	O
High-Grade	O
Urothelial	O
Carcinoma	O
___	O
ECHO	O
-	O
The	O
left	O
atrium	O
is	O
elongated.	O
Left	O
ventricular	O
wall	O
thickness,	O
cavity	O
size,	O
and	O
global	O
systolic	O
function	O
are	O
normal	O
(LVEF	O
=	O
65%).	O
Tissue	O
Doppler	O
imaging	O
suggests	O
an	O
increased	O
left	O
ventricular	O
filling	O
pressure	O
(PCWP>18mmHg).	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
diameters	O
of	O
aorta	O
at	O
the	O
sinus,	O
ascending	O
and	O
arch	O
levels	O
are	O
normal.	O
A	O
___	O
3	O
aortic	O
valve	O
bioprosthesis	O
is	O
present.	O
The	O
aortic	O
valve	O
prosthesis	O
appears	O
well	O
seated,	O
with	O
normal	O
leaflet/disc	O
motion	O
and	O
transvalvular	O
gradients.	O
No	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
borderline	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
___	O
MRI	O
Abdomen:	O
1.	O
Infiltrative	O
soft	O
tissue	O
mass	O
at	O
the	O
root	O
of	O
the	O
mesentery	O
and	O
along	O
the	O
distal	O
right	O
ureter	O
extending	O
to	O
the	O
bladder	O
dome.	O
2.	O
Re-	O
demonstration	O
of	O
a	O
right	O
subcapsular	O
renal	O
hematoma,	O
and	O
blood	O
products	O
within	O
the	O
renal	O
pelvis.	O
A	O
right-sided	O
percutaneous	O
nephrostomy	O
tube	O
is	O
in	O
place.	O
3.	O
Left	O
adrenal	O
gland	O
adenoma.	O
___	O
CT	O
Chest:	O
1.	O
No	O
evidence	O
of	O
metastatic	O
disease	O
within	O
the	O
chest.	O
2.	O
Mild	O
apical	O
predominant	O
centrilobular	O
emphysema.	O
Scattered	O
prominent	O
mediastinal	O
lymph	O
nodes.	O
___	O
___	O
Report:	O
Technically	O
successful	O
core	O
biopsy	O
of	O
the	O
mesenteric/retroperitoneal	O
mass.	O
___	O
Pathology:	O
Benign	O
pancreatic	O
tissue	O
with	O
no	O
specific	O
pathologic	O
changes.	O
Scant	O
fragment	O
of	O
fibroadipose	O
tissue	O
with	O
focal	O
myxoid	O
change.	O
___	O
___	O
Report:	O
Procedure	O
was	O
terminated	O
as	O
safe	O
window	O
could	O
not	O
be	O
identified	O
on	O
preprocedural	O
CT	O
images.	O
DISCHARGE	O
LABS:	O
___	O
07:39AM	O
BLOOD	O
WBC-4.7	O
RBC-3.05*	O
Hgb-7.9*	O
Hct-27.0*	O
MCV-89	O
MCH-25.9*	O
MCHC-29.3*	O
RDW-19.3*	O
RDWSD-62.4*	O
Plt	O
___	O
___	O
07:39AM	O
BLOOD	O
Glucose-100	O
UreaN-13	O
Creat-1.2*	O
Na-141	O
K-3.8	O
Cl-109*	O
HCO3-23	O
AnGap-13	O
Brief	O
Hospital	O
Course:	O
This	O
is	O
a	O
___	O
year	O
old	O
female	O
with	O
past	O
medical	O
history	O
of	O
aortic	O
stenosis	O
status	O
post	O
TAVR	O
___,	O
CAD	O
s/p	O
CABG	O
___,	O
peripheral	O
vascular	O
disease	O
admitted	O
with	O
abdominal	O
pain	O
and	O
R	O
hydronephrosis	O
after	O
a	O
failed	O
attempt	O
at	O
ureteral	O
stent,	O
requiring	O
R	O
percutaneous	O
nephrostomy	O
tube	O
placement,	O
course	O
complicated	O
by	O
perinephric	O
hematoma,	O
identification	O
of	O
abdominal	O
soft	O
tissue	O
mass,	O
now	O
status	O
post	O
operative	O
excision	O
of	O
right	O
ovary	O
and	O
pelvic	O
mass,	O
ready	O
for	O
discharge	O
home	O
with	O
scheduled	O
___	O
Oncology	O
follow-up	O
.	O
#	O
R	O
Obstructive	O
Uropathy	O
/	O
Right	O
Hydronephrosis	O
-	O
Patient	O
was	O
admitted	O
following	O
failed	O
attempt	O
at	O
cystoscopy	O
with	O
ureteral	O
stent	O
placement;	O
___	O
was	O
consulted	O
regarding	O
R	O
Percutaneous	O
Nephrostomy	O
Tube	O
placement.	O
This	O
was	O
successfully	O
placed.	O
Post-procedure	O
period	O
was	O
complicated	O
by	O
worsenign	O
R	O
sided	O
pain,	O
prompting	O
repeat	O
CT	O
scan	O
that	O
R	O
sided	O
perinephric	O
hematoma.	O
Patient	O
treated	O
conservatively,	O
was	O
transfused	O
2	O
units	O
pRBCs,	O
and	O
stabilized.	O
Patient	O
was	O
scheduled	O
for	O
follow-up	O
with	O
___	O
for	O
___	O
for	O
reassessment	O
of	O
tube.	O
.	O
#	O
Acute	O
on	O
chronic	O
abdominal	O
pain	O
/	O
Pelvic	O
mass	O
concerning	O
for	O
cancer	O
-	O
Patient's	O
course	O
notable	O
for	O
significant	O
R	O
abdominal	O
and	O
flank	O
pain.	O
Prior	O
imaging	O
and	O
imaging	O
during	O
this	O
admission	O
showed	O
an	O
infiltrative	O
pelvic	O
mass.	O
Her	O
pain	O
was	O
refractory	O
to	O
multiple	O
IV	O
and	O
PO	O
narcotic	O
agents,	O
but	O
did	O
improve	O
with	O
Tylenol	O
with	O
codeine	O
as	O
well	O
as	O
simethicone.	O
She	O
had	O
initially	O
been	O
planned	O
as	O
above	O
for	O
cystoscopy	O
with	O
stent	O
placement	O
and	O
biopsy,	O
but	O
were	O
unable	O
to	O
perform	O
either	O
given	O
difficult	O
anatomy.	O
Subsequently	O
multiple	O
services	O
were	O
consulted	O
for	O
biopsy	O
what	O
was	O
felt	O
to	O
be	O
a	O
technically	O
difficult	O
biopsy;	O
ERCP	O
was	O
unable	O
to	O
pass	O
scope	O
for	O
EUS-guided	O
biopsy,	O
initial	O
___	O
attempt	O
at	O
biopsy	O
did	O
not	O
yield	O
diagnostic	O
tissue	O
and	O
repeat	O
___	O
attempt	O
was	O
aborted	O
given	O
lack	O
of	O
safe	O
windows	O
for	O
biopsy.	O
Urology	O
then	O
underwent	O
a	O
laparoscopic	O
evaluation	O
that	O
showed	O
a	O
fixed	O
R	O
ovary	O
with	O
associated	O
mass.	O
She	O
underwent	O
R	O
oopherectomy	O
and	O
excision	O
of	O
mass,	O
with	O
prelim	O
pathology	O
showing	O
high	O
grade	O
transitional	O
carcinoma	O
with	O
extensive	O
lymphovascular	O
invasion.	O
She	O
was	O
discharged	O
with	O
long-	O
and	O
short-acting	O
codeine	O
for	O
pain	O
relief,	O
which	O
was	O
achieving	O
adequate	O
pain	O
control	O
on	O
the	O
day	O
of	O
discharge	O
per	O
patient	O
report,	O
and	O
close	O
follow-up	O
with	O
___	O
Oncology	O
and	O
___	O
GYN/ONC.	O
.	O
#	O
Social	O
Stressors	O
/	O
Anxiety	O
-	O
Patient	O
with	O
anxiety	O
and	O
labile	O
mood	O
this	O
admission,	O
relating	O
to	O
the	O
death	O
of	O
her	O
daughter	O
in	O
the	O
prior	O
6	O
months,	O
as	O
well	O
as	O
frustration	O
regarding	O
pain	O
and	O
difficulty	O
of	O
obtaining	O
biopsy	O
as	O
above.	O
Patient	O
was	O
seen	O
by	O
social	O
work	O
regularly,	O
reported	O
feeling	O
depressed	O
for	O
some	O
time.	O
As	O
such,	O
she	O
was	O
started	O
on	O
a	O
trial	O
of	O
citalopram	O
and	O
was	O
provided	O
continued	O
emotional	O
support.	O
.	O
#	O
Constipation	B-Constipation
-	O
course	O
was	O
complicated	O
by	O
constipation	B-Constipation
in	O
setting	O
of	O
poor	O
PO	O
intake	O
and	O
opiates.	O
Repsonded	O
to	O
improved	O
PO	O
intake	O
and	O
initiation	O
of	O
bowel	O
regimen	O
with	O
colace	O
and	O
senna,	O
as	O
well	O
as	O
simethicone	O
for	O
cramping	O
.	O
#	O
Hypertension	O
-	O
Has	O
historically	O
difficult	O
to	O
control	O
blood	O
pressure.	O
This	O
admission,	O
had	O
elevated	O
blood	O
pressures,	O
prompting	O
increasing	O
of	O
home	O
labetalol	O
dosing.	O
Continued	O
amLODIPine,	O
hydralazine,	O
isosorbide,	O
lisinopril	O
.	O
#	O
CAD	O
s/p	O
CABG	O
/	O
Aortic	O
Stenosis	O
status	O
post	O
Recent	O
TAVR	O
-	O
conitnued	O
ASA.	O
In	O
setting	O
of	O
perinephric	O
hematoma	O
and	O
operative	O
biopsy,	O
plavix	O
was	O
held	O
per	O
discussion	O
with	O
cardiology.	O
Restarted	O
plavix	O
once	O
she	O
was	O
stable.	O
Continued	O
Atorvastatin,	O
fenofibrate	O
.	O
#	O
Diabetes	O
type	O
2	O
-	O
Held	O
glimepiride	O
during	O
inpatient	O
stay,	O
restarted	O
at	O
discharge	O
.	O
#	O
GERD	O
-	O
continued	O
PPI	O
.	O
TRANSITIONAL	O
ISSUES:	O
-	O
Percutaneous	O
nephrostomy	O
tube	O
placed	O
this	O
admission;	O
discharged	O
home	O
with	O
services	B-Has_carers
for	O
continued	O
tube	O
care	O
-	O
RP	O
mass	O
biopsy	O
results	O
pending	O
on	O
discharge,	O
to	O
be	O
discussed	O
at	O
her	O
___	O
oncology	O
follow-up	O
with	O
Dr.	O
___	O
.	O
.	O
.	O
Time	O
in	O
care:	O
45	O
minutes	O
in	O
patient	O
care,	O
counseling,	O
care	O
coordination	O
and	O
other	O
discharge-related	O
activities	O
on	O
the	O
day	O
of	O
discharge.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
2.	O
amLODIPine	O
10	O
mg	O
PO	O
DAILY	O
3.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
4.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
5.	O
Cyclobenzaprine	O
5	O
mg	O
PO	O
DAILY:PRN	O
back	O
pain	O
6.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
DAILY	O
7.	O
HydrALAZINE	O
75	O
mg	O
PO	O
Q8H	O
8.	O
Labetalol	O
100	O
mg	O
PO	O
BID	O
9.	O
Lisinopril	O
40	O
mg	O
PO	O
DAILY	O
10.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
11.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
12.	O
Acetaminophen	O
w/Codeine	O
___	O
TAB	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Mild	O
13.	O
Ciprofloxacin	O
HCl	O
250	O
mg	O
PO	O
Q24H	O
14.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
30	O
mg	O
PO	O
DAILY	O
15.	O
Fenofibrate	O
200	O
mg	O
PO	O
DAILY	O
16.	O
glimepiride	O
0.5	O
mg	O
ORAL	O
DAILY	O
17.	O
LORazepam	O
0.5	O
mg	O
PO	O
QHS:PRN	O
insomnia	O
Discharge	O
Medications:	O
1.	O
Citalopram	O
20	O
mg	O
PO	O
DAILY	O
RX	O
*citalopram	O
20	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*14	O
Tablet	O
Refills:*0	O
2.	O
Codeine	O
Sulfate	O
15	O
mg	O
PO	O
Q4H:PRN	O
pain	O
RX	O
*codeine	O
sulfate	O
15	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
four	O
(4)	O
hours	O
Disp	O
#*50	O
Tablet	O
Refills:*0	O
3.	O
Docusate	O
Sodium	O
200	O
mg	O
PO	O
BID	O
RX	O
*docusate	O
sodium	O
100	O
mg	O
2	O
tablet(s)	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*56	O
Tablet	O
Refills:*0	O
4.	O
Senna	O
17.2	O
mg	O
PO	O
BID	O
RX	O
*sennosides	O
[senna]	O
8.6	O
mg	O
2	O
tablets	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*56	O
Tablet	O
Refills:*0	O
5.	O
Simethicone	O
80	O
mg	O
PO	O
QID	O
RX	O
*simethicone	O
80	O
mg	O
1	O
tablet	O
by	O
mouth	O
four	O
times	O
a	O
day	O
Disp	O
#*56	O
Tablet	O
Refills:*0	O
6.	O
Acetaminophen	O
w/Codeine	O
___	O
TAB	O
PO	O
Q4H:PRN	O
Pain	O
-	O
Moderate	O
RX	O
*acetaminophen-codeine	O
300	O
mg-30	O
mg	O
___	O
tablet(s)	O
by	O
mouth	O
every	O
four	O
(4)	O
hours	O
Disp	O
#*100	O
Tablet	O
Refills:*0	O
7.	O
Labetalol	O
300	O
mg	O
PO	O
BID	O
RX	O
*labetalol	O
300	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*28	O
Tablet	O
Refills:*0	O
8.	O
amLODIPine	O
10	O
mg	O
PO	O
DAILY	O
9.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
10.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
11.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
12.	O
Cyclobenzaprine	O
5	O
mg	O
PO	O
DAILY:PRN	O
back	O
pain	O
13.	O
Fenofibrate	O
200	O
mg	O
PO	O
DAILY	O
14.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
DAILY	O
15.	O
glimepiride	O
0.5	O
mg	O
ORAL	O
DAILY	O
16.	O
HydrALAZINE	O
75	O
mg	O
PO	O
Q8H	O
17.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
30	O
mg	O
PO	O
DAILY	O
18.	O
Lisinopril	O
40	O
mg	O
PO	O
DAILY	O
19.	O
LORazepam	O
0.5	O
mg	O
PO	O
QHS:PRN	O
insomnia	O
20.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
21.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
#	O
R	O
Obstructive	O
Uropathy	O
/	O
R	O
hydronephrosis	O
#	O
R	O
perinephric	O
hematoma	O
#	O
Acute	O
on	O
chronic	O
abdominal	O
pain	O
/	O
Pelvic	O
mass	O
#	O
Hypertension	O
#	O
Constipation	B-Constipation
#	O
Depression	O
/	O
Anxiety	O
#	O
Hyperlipidemia	O
#	O
CAD	O
#	O
Diabetes	O
type	O
2	O
#	O
GERD	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Ms	O
___,	O
It	O
was	O
a	O
pleasure	O
caring	O
for	O
you	O
at	O
___.	O
You	O
were	O
admitted	O
after	O
an	O
attempted	O
placement	O
of	O
a	O
stent	O
in	O
your	O
ureter.	O
You	O
were	O
seen	O
by	O
radiology	O
experts	O
who	O
placed	O
a	O
right	O
percutaneous	O
nephrostomy	O
tube	O
to	O
drain	O
your	O
right	O
kidney.	O
During	O
your	O
hospital	O
course	O
you	O
developed	O
a	O
hematoma	O
(bruise)	O
around	O
your	O
kidney.	O
You	O
were	O
monitored	O
and	O
this	O
stabilized.	O
You	O
had	O
persistent	O
pain	O
and	O
were	O
found	O
to	O
have	O
a	O
pelvic	O
mass.	O
You	O
underwent	O
a	O
biopsy	O
and	O
removal	O
of	O
your	O
right	O
ovary.	O
Your	O
pain	O
is	O
controlled	O
and	O
you	O
are	O
now	O
ready	O
for	O
discharge	O
home,	O
with	O
follow-up	O
with	O
___	O
Oncology	O
and	O
___	O
GYN	O
Oncology.	O
The	O
following	O
are	O
instructions	O
from	O
the	O
Urology	O
and	O
Interventional	O
Radiology	O
teams:	O
-	O
No	O
vigorous	O
physical	O
activity	O
or	O
sports	O
for	O
4	O
weeks,	O
including	O
sexual	O
activity.	O
Avoid	O
lifting/twisting/bending/pulling/pushing	O
items	O
weighing	O
more	O
than	O
a	O
___	O
pounds.	O
PERCUTANEOUS	O
NEPHROSTOMY	O
(PCN)	O
TUBE	O
INSTRUCTIONS	O
FOR	O
CARE:	O
-	O
Please	O
leave	O
PCN	O
tube	O
to	O
external	O
gravity	O
drainage.	O
-	O
Catheter	O
flushing:	O
If	O
there	O
are	O
excessive	O
blood	O
clots	O
or	O
debris	O
or	O
thick	O
urine	O
within	O
the	O
connecting	O
tubing,	O
this	O
can	O
be	O
gently	O
flushed	O
as	O
needed	O
to	O
promote	O
clearing.	O
Use	O
normal	O
saline	O
filled	O
syringes	O
provided	O
by	O
nursing.	O
-	O
Change	O
every	O
3	O
days,	O
if	O
soiled/saturated,	O
as	O
needed:	O
Gently	O
cleanse	O
around	O
the	O
skin	O
entry	O
site	O
of	O
the	O
catheter	O
with	O
gentle	O
soap	O
w/	O
warm	O
water.	O
Dry	O
and	O
apply	O
gauze	O
dressing.	O
-	O
Catheter	O
security:	O
a)	O
EVERYDAY	O
you	O
must	O
check	O
to	O
be	O
sure	O
the	O
catheter,	O
the	O
connecting	O
tubing	O
and	O
the	O
drainage	O
bag	O
are	O
securely	O
attached	O
to	O
the	O
patient	O
and	O
are	O
not	O
kinked.	O
b)	O
If	O
the	O
catheter	O
appears	O
to	O
be	O
pulling	O
"out",	O
please	O
notify	O
Interventional	O
Radiology.	O
c)	O
If	O
the	O
catheter	O
pulls	O
out,	O
please	O
notify	O
Interventional	O
Radiology	O
within	O
8	O
hours.	O
SAVE	O
THE	O
CATHETER	O
for	O
inspection--DO	O
NOT	O
throw	O
it	O
away.	O
-	O
Call	O
Interventional	O
Radiology/Angio	O
for	O
ANY	O
catheter	O
related	O
questions	O
or	O
problems.	O
Call	O
___	O
or	O
have	O
the	O
Fellow/Resident	O
(pager#	O
___	O
paged	O
with	O
questions.	O
Followup	O
Instructions:	O
___	O

